Valeant Pharmaceuticals Reports First Quarter 2014 Financial Results

[PR Newswire] – LAVAL, Quebec, May 8, 2014 /PRNewswire/ — 2014 First Quarter Total Revenue $1.9 billion; an increase of 77% over the prior year Exceeded our expectations Launched 11 new products in the U.S. Positive … more

View todays social media effects on VRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Valeant is hiring next, click here to view